The Central Nervous System Disorders Therapeutics market continues to evolve rapidly, propelled by increasing prevalence of neurological and psychiatric conditions worldwide. As new treatment modalities and innovative drug developments emerge, the industry landscape reflects significant opportunities for enhanced patient outcomes and business growth. Market Size and Overview The Global Central Nervous System Disorders Therapeutics Market size is estimated to be valued at USD 97,028.1 million in 2025 and is expected to reach USD 159,583.2 million by 2032, exhibiting a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032. Central Nervous System Disorders Therapeutics Market Growth is supported by advancements in biopharmaceutical research, increased adoption of specialty therapeutics, and a widening patient base impacted by CNS disorders such as Alzheimer’s, Parkinson’s, epilepsy, and multiple sclerosis. ‣ Get more insights on : Central Nervous System Disorders Therapeutics Market ‣ Get this Report in Japanese Language: 中枢神経系疾患治療市場 ‣ Get this Report in Korean Language: 중추신경계장애치료제시장